Press Releases BB Biotech AG

Equities

BION

CH0038389992

Market Closed - Swiss Exchange Other stock markets 11:31:30 2024-04-26 am EDT			5-day change	1st Jan Change
40.45 ^CHF	-0.25%		-2.29%	-5.38%

Apr. 26	Switzerland's BB Biotech Swings to Q1 Profit; Operating Income Jumps	MT
Apr. 25	BB Biotech AG Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates	Apr. 26	EQ
BB Biotech AG publishes its interim report	Apr. 26	EQ
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	Mar. 26	EQ
DD: BB BIOTECH AG: Dr. Thomas von Planta, buy	Mar. 26	EQ
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share	Mar. 21	EQ
DD: BB BIOTECH AG: Prof. Dr. Mads Krogsgaard Thomsen, buy	Feb. 21	EQ
BB Biotech AG publishes its 2023 annual report	Feb. 16	EQ
Investor interest returns – dividend yield remains high for 2024	Feb. 14	EQ
BB Biotech AG: End of year biotech equity market rally – M&A and end of rate hike cycle	Jan. 19	EQ
BB Biotech AG publishes financial results for 2023 and changes to the Board of Directors	Jan. 19	EQ
BB Biotech AG publishes its interim report	23-10-20	EQ
BB BIOTECH AG: Biotech equity markets in flux: the impact of rising bond yields and shifting healthcare policies	23-10-20	EQ
BB Biotech : Q3 2023 Interim Report	23-10-19	PU
BB Biotech : Delisting from Borsa Italiana	23-08-21	PU
BB Biotech AG publishes its interim report	23-07-21	EQ
BB BIOTECH AG: Sector rotation and fund outflows weigh on biotech stocks, but positive developments allow fund raising to strengthen industry	23-07-21	EQ
BB BIOTECH AG: Creating blockbuster drugs using algorithms	23-05-03	EQ
BB BIOTECH AG: Lackluster first quarter for biotech stocks	23-04-21	EQ
BB Biotech AG publishes its interim report	23-04-21	EQ
Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.85 per share	23-03-23	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases BB Biotech AG

Equities

BION

CH0038389992

Press Releases

Filters